Bayer (Dynamic Shared Ownership)
The largest corporate Beta experiment is, so far, a cost-cutting story
Bayer's Dynamic Shared Ownership is the biggest attempt to apply team-of-teams principles in a listed conglomerate: about 2,000 teams of six to ten, 90-day cycles, half the management layers removed. It is cited everywhere as proof that Beta has reached the mainstream. On the evidence available, it is a headcount programme with Beta vocabulary.
Last reviewed: 16 September 2026
Why this status
Twelve thousand jobs cut, half of management removed, a EUR 2bn savings target - and no published evidence yet of better outcomes, faster decisions or higher engagement. Cite it as an experiment in progress, never as a result.
What makes it a Beta case
- Dynamic Shared Ownership (from 2024, CEO Bill Anderson, designed with McKinsey): about 2,000 teams of six to ten people organised around products and customers instead of functions.
- 90-day cycles replace annual planning; teams set their own priorities within a mission frame.
- Management layers cut by about half, with two thirds of leadership positions removed; the target is EUR 2bn of savings by the end of 2026.
- Harvard Business School has a case study; Corporate Rebels use it as the flagship of "crossing the chasm".
What is documented
- Scale: roughly 12,000 positions cut cumulatively by 2026, management reduced by about 50%.
- Q2 2026: revenue EUR 10.9bn (+2.2%), EBITDA up, outlook confirmed; free cash flow negative.
- The share price recovered in June 2026 - because of the US Supreme Court ruling on glyphosate, not because of the organisation.
Where it cracks
- There is no published outcome evidence: no decision-speed measure, no engagement trend, no innovation indicator that can be attributed to DSO rather than to the cuts.
- Forbes (January 2025) and others describe the year-one experience as chaos in the middle, with former managers unsure of their roles - the "zombie structure" pattern from the research on self-managing organisations.
- The programme was designed top-down with a consulting firm and rolled out with a savings target. That is the opposite of the Beta transition literature (invitation, whole-system, no slicing).
- OrgTopologies reads DSO as "small hierarchies" reorganised around missions, not as self-organisation.
Verdict
Bayer is the case people will ask about, because it is the one they have read about. The answer is: it is not a case yet. Removing managers is not Beta; what replaces them is. Until Bayer publishes something that shows the teams work better - not just cheaper - DSO is a downsizing with a promising vocabulary. Watch it; do not cite it.
For a talk
Bayer removed half its managers and calls it shared ownership - nobody has yet shown that anything except the cost went down.
Sources
- Fierce Pharma: Bayer's layoff count now 12,000-plus (2026)
- Bayer: Q2 2026 results (2026-08)
- Forbes: Cutting middle management - Bayer's costly experiment one year later (2025-01-07)
- OrgTopologies: Studying org designs of Haier's RDHY and Bayer's DSO (2025-02)
- CNBC: Supreme Court Roundup ruling (2026-06-25)
- Corporate Rebels: Why 2026 might be a turning point for radically decentralized organizations (2026-01-01)
Read next
- How a transition actually works (Library)
- The case against self-organization (Library)